StockData
Cognition Therapeutics Inc logo

Cognition Therapeutics Inc (CGTX) bonds

CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.60−0.03 (-4.75%)

Close on Nov 18, 2026Market cap $57.06MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Cognition Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Cognition Therapeutics's 10-Q for the period ended Oct 31, 2025

IssueCouponAmount issuedCarrying value
Insurance Premium Financing Agreement8.65%$721.00K–
Insurance Premium Financing Agreement 28.65%$356.00K–
Insurance Premium Financing Agreement 37.95%$381.00K$307.00K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?